Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Invesco Health Care Fund earns a Low Process Pillar rating. The main driver of the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in its five-year alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback